Iga nephropathy

Kidney International

Volumn 47, Issue 2, 1995, Pages 377-387

  Galla, John H ^a,b  

^a Univ of Cincinnati Medical Center ^*

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; DAPSONE; DIPYRIDAMOLE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; PHENYTOIN; PREDNISONE; UROKINASE; WARFARIN;

CLINICAL FEATURE; GLUTEN FREE DIET; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; TONSILLECTOMY;

EID: 0028934504     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.50     Document Type: Article

References (148)

1. BERGER J, HINGLAIS N: Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695, 1968
2. BERGER J: IgA glomerular deposits in renal disease. Transplant Proc 1:939-944, 1969
3. MESTECKY J: The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7:265-276, 1987
4. MESTECKY J: Immunobiology of IgA. Am J Kidney Dis 12:378-383, 1988
5. MESTECKY J, RUSSELL MW, JACKSON S, BROWN TA: The human IgA system: a reassessment. Clin Immunol Immunopathol 40:105-114, 1986
6. KILIAN M: Degradation of immunoglobulins A1, A2 and G by suspected principal peridontal pathogens. Infect Immun 34:757-765, 1981
7. LAMM M: The IgA mucosal immune system. Am J Kidney Dis 12:384-387, 1988
8. JULIAN BA, WALDO FB, RIFAI A, MESTECKY J: IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84:129-132, 1988
9. UEDA Y, SAKAI O, YAMAGATA M, KITAJIMA T, KAWAMURA K: IgA glomerulonephritis in Japan. Contrib Nephrol 4:36-47, 1977
10. LEVY M, BERGER J: Worldwide perspective of IgA nephropathy. Am J Kid Dis 12:340-347, 1988
11. MELEG-SMITH S, TUNG KSK: Incidence of IgA-related nephritidies in American Indians in New Mexico. Hum Pathol 16:181-184, 1985
12. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209-215, 1990
13. HOGG RJ: Usual and unusual presentations of IgA nephropathy in children. Contrib Nephrol 104:14-23, 1993
14. SISSONS JGP, WOODROW DF, CURTIS JR, EVANS DJ, GOWER PE, SLOPER JG, PETERS DK: Isolated glomerulonephritis with mesangial IgA deposits. Brit Med J 3:611-614, 1975
15. PROPPER DJ, POWER DA, SIMPSON JG, EDWARD N, CATTO GRD: The incidence, mode of presentation, and prognosis of IgA nephropathy in Northeast Scotland. Semin Nephrol 7:363-366, 1987
16. GALLA JH, KOHAUT EC, ALEXANDER RC, MESTECKY J: Racial differences in the prevalence of IgA-associated nephropathies. Lancet 2:522, 1985
17. JENNETTE JC, WALL SD, WILKMAN AS: Low incidence of IgA nephropathy in blacks. Kidney Int 28:944-950, 1985
18. WANG AC, FUDENBURG HH: Genetics and evolution of human immunoglobulin A. Adv Exp Med Biol 45:161-165, 1974
19. NEELAKANTAPPA K, GALLO GR, BALDWIN DS: Immunoglobulin A nephropathy in blacks and homozygosity for the genetic marker A2m. Ann Int Med 104:287, 1986
20. CROWLEY-NOWICK PA, JULIAN BA, WYATT RJ, GALLA JH, WALL BM, WARNOCK DG, MESTECKY J, JACKSON S: IgA nephropathy in blacks: Studies of IgA2 allotypes and clinical course. Kidney Int 39:1218-1224, 1991
21. JULIAN BA, WYATT RJ, WALDO FB, KOOPMAN WJ, JACKSON S, SCHROHENLOHER RE, GALLA JH, MESTECKY J, CZERKINSKY C: Immunological studies of IgA nephropathy: Familial and racial aspects, in Recent Advances in Mucosal Immunology, edited by MCGHEE JR, MESTECKY J, OGRA PL, BIENENSTOCK J, New York, Plenum Publishing Corp., 1987, pp 1489-1498
22. DEWERRA P, MOREL-MAROGER L, LEROUX-ROBERT C, RICHET G: Glomerulites a depots d'IgA diffus dans le mesangium. Etude de 96 cas chez l'adulte. Schweiz Med Wochenschr 103:761-768 and 797-803, 1973
23. TOLKOFF-RUBIN N, COSIMI AB, FULLER T, RUBIN RH, COLVIN RB: IgA nephropathy in HLA-identical siblings. Transplantation 26:430-433, 1978
24. EGIDO J, JULIAN BA, WYATT RJ: Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 2:134-142, 1987
25. JULIAN BA, QUIGGINS PA, THOMPSON JS, WOODFORD SY, GLEASON K, WYATT RJ: Familial IgA nephropathy. Evidence for an inherited mechanism of disease. N Engl J Med 312:202-208, 1985
26. SCHENA FP, SCIVITTARO V, RANIERI E: IgA nephropathy: Pros and cons for a familial disease. Contrib Nephrol 104:36-45, 1993
27. MACDONAL IM, DUMBLE LJ, KINCAID-SMITH P: HLA and glomerulonephritis, in HLA and Disease, Paris, INSERM, 1976, p 203
28. HIKI Y, KOBAYASHI Y, TATENO S, SADA M, KASHIWAGI N: Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32:222-226, 1982
29. BERTHOUX FC, ALAMARTINE E. LAURENT B, BERTHOUX P, VACHEROT C, LAMBERT C, LE PETIT J-C: Primary IgA glomerulonephritis and MHC revisited. Contrib Nephrol 104:54-60, 1993
30. FREEDMAN BI, SPRAY BJ, HEISE ER: HLA associations in IgA nephropathy and focal and segmentai glomerulosclerosis. Am J Kidney Dis 23:352-357, 1994
31. CLARKSON AR, SEYMOUR AE, THOMPSON AJ, HAYNES WDG, CHAN Y-L, JACKSON B: IgA nephropathy: A syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 8:458-471, 1977
32. WALSHE JJ, BRENTJENS JP, COSTA GG, ANDRES GA, VENUTO RC: Abdominal pain associated with IgA nephropathy. Am J Med 77:765-767, 1984
33. NICHOLLS K, WALKER RG, DOWLING JP, KINCAID-SMITH P: "Malignant" IgA nephropathy. Am J Kidney Dis 5:42-46, 1985
34. WELCH TR, MCADAMS AJ, BERRY A: Rapidly progressive IgA nephropathy. Am J Dis Child 142:789-793, 1988
35. Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children. Kidney Int 22:643-652, 1982
36. LEVY M, GONZALEZ-BURCHARD G, BROYER M, DOMMERGUES JP, FOULARD M, SOREZ JP, HABIB R: Berger's disease in children. Medicine 64:157-180, 1985
37. MUSTONEN J, PASTERNACK A: Associated diseases in IgA nephropathy, in IgA Nephropathy, edited by CLARKSON AR, Boston, Martin Nijhoff Publishing, 1987, pp 47-65
38. KIMMEL PL, PHILLIPS TM, FERREIRA-CENTENO A, FARKAS-SZALLASI T, ABRAHAM AA, GARRETT CT: Idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 327:702-706, 1992
39. KATZ A, BARGMAN JM, MILLER DC, GUO J-W, SALEH GHALI V, SCHOENEMAN MJ: IgA nephritis in HIV-positive patients: A new HIV-associated nephropathy? Clin Nephrol 38:61-68, 1992
40. ROTH DA, WILZ DR, THEIL GB: Schoenlein-Henoch syndrome in adults. Quart J Med 55:145-152, 1985
41. HYMAN LR, WAGNILD JP, BEIRNE GJ, BURKHOLDER PM: Immunoglobulin-A distribution in glomerular disease: Analysis of immunofluorescence localization and pathogenetic significance. Kidney Int 3:397-408, 1973
42. MCCOY RC, ABRAMOWSKY CR, TISHER CC: IgA nephropathy. Am J Pathol 76:123-144, 1974
43. LEVY M, BEAUFILS H, GUBLER MC, HABIB R: Idiopathic recurrent macroscopic haematuria and mesangial IgA-IgG deposits in children (Berger's disease). Clin Nephrol 1:63-69, 1973
44. JENNETTE JC: The immunohistology of IgA nephropathy. Am J Kidney Dis 12:348-352, 1988
45. LAI KN: The cellular immunity and nature of IgA molecules in IgA nephropathy. Contrib Nephrol 104:99-111, 1993
46. TOMINO Y, SAKAI H, ENDOH M, MIURA M, SUGA T, KANESHIGE H, NOMOTO Y: Cross-reactivity of eluted antibodies from renal tissues of patients with Henoch-Schönlein purpura nephritis and IgA nephropathy. Am J Nephrol 3:315-318, 1983
47. MONTOLIU J, DARNELL A, TORRAS A, LENS XM, REVERT L: Absence of IgA in the glomerular deposits of patients with cirrhosis of the liver and glomerulopathy. Proc Eur Dial Transplant 22:784-789, 1985
48. D'AMICO G: Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 12:353-357, 1988
49. LAI K-N, CHUI S-H, LAI FM, LAM CWK: Predominant synthesis of IgA with lambda light chain in IgA nephropathy. Kidney Int 33:584-589, 1988
50. GALLA JH, SPOTSWOOD M, HARRISON LA, MESTECKY J: Urinary immunoglobulins in IgA-nephropathy and Henoch-Schoenlein purpura. J Clin Immunol 5:298-306, 1985
51. ZIMMERMAN SW, BURKHOLDER PM: Immunoglobulin A nephropathy. Arch Int Med 135:1217-1223, 1975
52. JULIAN BA, WYATT RJ, MCMORROW RG, GALLA JH: Serum complement proteins in IgA nephropathy. Clin Nephrol 20:251-258, 1983
53. WYATT RJ: The complement system in IgA nephropathy and Henoch-Schoenlein purpura: Functional and genetic aspects. Contrib Nephrol 104:82-91, 1993
54. CEDERHOLM B, WIESLANDER J, BYGREN P, HEINGARD D: Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 85:4865-4868, 1988
55. JENNETTE JC, WIESLANDER J, TUTTLE R, FALK RJ: IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura. Diagnostic value and pathologic implications. Am J Kidney Dis 18:460-471, 1991
56. BALDREE LA, WYATT RJ, JULIAN BA, FALK RJ, JENNETTE JC: Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am J Kidney Dis 22:1-4, 1993
57. SHEN G, RITTENHOUSE HG, HAWKINS B, CHENG IKP, PETER JB: Detection of IgA-Fn aggregates in Chinese patients with IgA nephropathy and glomerulonephritis. (abstract) J Am Soc Nephrol 2:604, 1991
58. DAVIN JC, LI VECCHI M, NAGY J, FOIDART JM, FOIDART JB, BARBAGALLO, SANGIORGI G, MALAISE M, MAHIEU P: Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy. J Clin Immunol 11:78-94, 1991
59. FLOEGE J, EITNER F, SCHULZE M, BRUNCKHORST R, SCHMIDT RE, KOCH KM: Plasma IgA-fibronectin complexes (IgA-FN-C) in IgA nephropathy patients: An artifact? (abstract) J Am Soc Nephrol 4:677, 1993
60. O'DONOGHUE DJ, NUSBAUM P, NOEL LH, HALBWACHS-MECARELLI L, LESAVRE P: Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura. Nephrol Dial Transplant 7:534-538, 1992
61. CZERKINSKY C, CRAGO SS, KOOPMAN WJ, JACKSON S, SCHROHENLOHER RE, GALLA J, MESTECKY J: The occurrence of circulating IgA-IgG immune complexes in IgA associated renal diseases, in Mucosal Immunity, IgA and Polymorphonuclear Neutrophils, edited by REVILLARD JP, VIOSIN C, WIERZBICKI N, Suresnes France, Foundation Francoallemande, 1985, pp 295-297
62. CZERKINSKY C, KOOPMAN WJ, JACKSON S, COLLINS JE, CRAGO SS, SCHROHENLOHER RE, JULIAN BA, GALLA JH, MESTECKY J: Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 77:1931-1938, 1986
63. SAULSBURY FT: IgA rheumatoid factor in Henoch-Schoenlein purpura. J Pediatr 108:71-76, 1986
64. BAART DE LA FAILLE-KUYPER EH, KATER L, KUIJTEN RH, KOOIKER CJ, WAGENAAR SS, VAN DER ZOUWEN P, DOURHOUT MEES EJ: Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int 9:424-429, 1976
65. HASBARGEN JA, COPLEY JB: Utility of skin biopsy in the diagnosis of IgA nephropathy. Am J Kidney Dis 6:100-102, 1985
66. LAMM ME, EMANCIPATOR SN, GALLO GR: Relevance of an experimental model to clinical IgA nephropathy. Contrib Nephrol 40:32-36, 1984
67. RIFAI A, SMALL P JR, AYOUB EM: Experimental IgA nephropathy. Contrib Nephrol 40:37-44, 1984
68. SCIVITTARO V, AMORE A, EMANCIPATOR SN: Animal models as a means to study IgA nephropathy. Contrib Nephrol 104:65-78, 1993
69. DE HEER E, GORTER A, VAN DER WAL AM, VAN EDENBURG JDH, ROZING J, BRUJIN JA, DAHA MR: Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1 antibody in the rat (abstract). J Am Soc Nephrol 4:599, 1993
70. COPPO R: The pathogenetic potential of environmental antigens in IgA nephropathy. Am J Kidney Dis 12:420-424, 1988
71. DELACROIX DL, ELKON KB, GEUBEL AP, HODGSON HF, DIVE C, VAERMAN JP: Changes in size, subclass, and metabolic properties of serum immunoglobulin A in live diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71:358-367, 1983
72. VAN DEN WALL BAKE AWL, DAHA MR, VAN DER ARK A, HIEMSTRA PS, RADL J, VAN Es LA: Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol 74:115-120, 1988
73. VAN DEN WALL BAKE AWL, DAHA MR, EVERS-SCHOUTEN J, VAN ES LA: Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: Evidence for the bone marrow as a source of mesangial IgA. Am J Kidney Dis 12:410-414, 1988
74. LAYWARD L, ALLEN AC, HATTERSLEY JM, HARPER SJ, FEEHALLY J: Elevation of IgA in IgA nephropathy is localized to the serum and not saliva and is restricted to IgAl subclass. Nephrol Dial Transplant 8:25-28, 1993
75. LAYWARD L, FINNEMORE AM, ALLEN AC, HARPER SJ, FEEHALLY J: Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol 69:306-313, 1993
76. BROWN TA, CLEMENTS ML, MURPHY BR, RADL J, HAAIJMAN JJ, MESTECKY J: Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza vaccine. Adv Exp Med Biol 2166:1691-1700, 1987
77. SANCHO J, EGIDO J, RIVERA F, HERNANDO L: Immune complexes in IgA nephropathy: Presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. Clin Exp Immunol 54:194-202, 1983
78. COPPO R, AMORE A, ROCCATELLO D: Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2:S173-S180, 1992
79. RUSSELL MW, MESTECKY J, JULIAN BA, GALLA JH: IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J Clin Immunol 6:74-86, 1986
80. ROSTOKER G, PETIT-PHAR M, DEL PRATO S, TERZIDIS H, LANG P, DUBERT JM, WEIL B, LAGRUE G: Mucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertorie to food and airborne antigens. Nephron 59:561-566, 1991
81. ANDRÉ C, BERTHOUX FC, ANDRÉ F, GILLON J, GENIN C, SABATIER J-C: Prevalence of IgA2 deposits in IgA nephropathies: A clue to their pathogenesis. N Engl J Med 303:1343-1346, 1980
82. CONLEY ME, COOPER MD, MICHAEL AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66:1432-1436, 1980
83. TOMINO Y, ENDOH M, NOMOTO Y, SAKAI H: Immunoglobulin A1 in IgA nephropathy. N Engl J Med 305:1159-1160, 1981
84. LOMAX-SMITH JD, ZABROWARNY LA, HOWARTH GS, SEYMOUR AE, WOODROFFE AJ: The immunochemical characterization of mesangial IgA deposits. Am J Pathol 113:359-364, 1983
85. RAJARAMAN S, GOLDBLUM RM, CAVALLO T: IgA-associated glomerulonephritides: A study with monoclonal antibodies. Clin Immunol Immunopathol 39:514-522, 1986
86. KOMATSU N, NAGURA H, WATANABE K, NOMOTO Y, KOBAYASHI K: Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy. Nephron 33:61-64, 1983
87. EGIDO J, SANCHO J, MAMPASO F, LOPEZ-TRASCASA M, SANCHEZCRESPO M, BLASCO R, HERNANDO L: A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. Proc Eur Dial Transplant Assoc 17:660-666, 1980
88. VALENTIJN R, RADL J, HAAIJMAN J, VERMEER B, WEENING J, KAUFMANN RH, DAHA MR, VAN ES LA: Circulating and mesangial secretory component-binding IgA1 in primary IgA nephropathy. Kidney Int 26:760-766, 1984
89. MONTEIRO RC, HALBWACHS-MECARELLI L, ROQUE-BARREIRA MC, NOEL L-H, BERGER J, LESAVRE P: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671, 1985
90. MESTECKY J, WALDO FB, BRITT WJ, JULIAN BA, TOMANA M, VAN DEN WALL BAKE AWL, RUSSELL MW, GALLA JH, MOLDOVEANU Z, JACKSON S: Exogenous antigens deposited in the glomeruli of patients with IgA nephropathy, in Pathogenesis of IgA Nephropathy, edited by SAKAI H, SAKAI O, NOMOTO Y, Tokyo, Harcourt Brace, 1991, pp 247-257
91. JACKSON S, MONTGOMERY RI, JULIAN BA, GALLA JH, CZERKINSKY C: Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies. Clin Immunol Immunopathol 45:208-213, 1987
92. JACKSON S: Immunoglobulin-antiimmunoglobulin interactions and immune complexes in IgA nephropathy. Am J Kidney Dis 12:425-429, 1988
93. BÉNÉ M-C, CANTON P, AMEIL C, MAY T, FAURE G: Absence of mesangial IgA in AIDS: A postmortem study. Nephron 58:240-241, 1991
94. O'DONOGHUE DJ, DARVILL A, BALLARDIE FW: Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schoenlein purpura. J Clin Invest 88:1522-1530, 1991
95. CHAN TM, FRAMPTON G, JAYNE DRW, PERRY GJ, LOCKWOOD CM, CAMERON JS: Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: A longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasmic antibodies. Am J Kidney Dis 22:387-392, 1993
96. WYATT RJ, JULIAN BA: Activation of complement in IgA nephropathy. Am J Kidney Dis 12:437-442, 1988
97. WAXMAN FJ, HEBERT LA, COSIO FG, SMEAD WL, VANAMAN ME, TAGUIAM JM, BIRMINGHAM DJ: Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. J Clin Invest 77:82-89, 1986
98. LAI KN, LAI FM, CHUI SH, CHAN YM, TSAO GS, LEUNG KN, LAM CWK: Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy. Clin Nephrol 28:281-287, 1987
99. SAKAI H, MIYAZAKI M, ENDOH M, NOMOTO Y: Increase in IgA-specific switch T cells in patients with IgA nephropathy. Clin Exp Immunol 78:378-382, 1989
100. LAYWARD L, ALLEN AC, HATTERSLEY JM, HARPER SJ, FEEHALLY J: Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. Clin Nephrol 40:131-136, 1993
101. DEMAINE AG, RAMBAUSEK M, KNIGHT JF, WILLIAMS DG, WELSH KI, RITZ E: Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J Clin Invest 81:611-614, 1988
102. FEEHALLY J, BEATTIE TJ, BRENCHLEY PEC, COUPES BM, MALLICK NP, POSTLETHWAITE RJ: Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 30:924-931, 1986
103. BANNISTER KM, DREW PA, CLARKSON AR, WOODROFFE AJ: Immunoregulation in glomerulonephritis, Henoch-Schönlein purpura and lupus nephritis. Clin Exp Immunol 53:384-390, 1983
104. SCHENA FP, MASTROLIITI G, FRACASSO AR, PASTORE A, LADISA N: Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy. Clin Nephrol 26:163-168, 1986
105. HALE GM, MCINTOSCH SL, HIKI Y, CLARKSON AR, WOODROFFE AJ: Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy. Kidney Int 29:718-724, 1986
106. JACKSON S, GALLA JH, KIRK KA, THORN BT, JULIAN BA: Epstein-Barr virus transformation of B lymphocytes from IgA nephropathy patients and first-degree relatives results in increased immunoglobulin synthesis not restricted to IgA. Am J Kidney Dis 17:55-61, 1991
107. GONZALEZ-CABRERO J, DE NICHOLAS R, HERNANDO L, EGIDO J: Expression and synthesis of cross-reactive antibodies by peripheral blood lymphocytes and their suppression by antiidiotypes in patients with IgA nephropathy. J Immunol 147:4162-4166, 1991
108. VAN DEN WALL BAKE AWL: Mechanisms of IgA deposition on the mesangium. Contrib Nephrol 104:138-146, 1993
109. VAN DEN WALL BAKE AWL, BRUIJN JA, ACCAVITTI MA, CROWLEY-NOVICK PA, SCHROHENLOHER RE, JULIAN BA, JACKSON S, KUBAGAWA H, COOPER MD, DAHA MR, MESTECKY J: Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. Kidney Int 44:65-74, 1993
110. TOMANA M, KULHAVY R, MESTECKY J: Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762-770, 1988
111. MESTECKY J, TOMANA M, CROWLEY-NOWICK PA, MOLDOVEANU Z, JULIAN BA, JACKSON S: Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993
112. DAVIN JC, MALAISE M, FOIDART J, MAHIEU P: Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy. Kidney Int 31:1132-1139, 1987
113. JULIAN BA, CANNON VR, WALDO FB, EGIDO J: Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy. Am J Kidney Dis 17:472-479, 1991
114. CHAUVEAU D, DROZ D: Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1-5, 1993
115. D'AMICO G, RAGNI A, GANDINI E, FELLIN G: Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol 104:6-13, 1993
116. WYATT RJ, JULIAN BA, WOODFORD SY, WANG C, ROBERTS J, THOMPSON JS, CHRISTENSON MJ, MCLEAN RH: C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 36:1-5, 1991
117. BERTHOUX FC, ALAMARTINE E, POMMIER G, LE PETIT J-C: HLA B35 antigen as a prognostic factor. N Engl J Med 319:1609-1610, 1988
118. GLASSOCK RJ: Treatment of immunologically mediated glomerular disease. Kidney Int 42:S121-S126, 1993
119. CLARKSON AR, WOODROFFE AJ, BANNISTER KM, ODUM J: Therapy in IgA nephropathy. Contrib Nephrol 104:189-197, 1993
120. LAI KN, LAI FM, HO CP, CHAN KW: Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol 26:174-180, 1986
121. KOBAYASHI Y, FUJII K, HIKI Y, TATENO S, KUROKAWA A, KAMIYAMA M: Steroid therapy in IgA nephropathy: A retrospective study in heavy proteinuric cases. Nephron 48:12-17, 1988
122. WALDO FB, ALEXANDER R, WYATT RJ, KOHAUT EC: Alternate-day prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 13:55-60, 1989
123. JULIAN BA, BARKER C: Alternate-day prednisone therapy in IgA nephropathy. Contrib Nephrol 104:198-206, 1993
124. JULIAN BA, BARKER CV, WOODFORD SY: Alternate-day prednisone treatment of patients with IgA nephropathy. (abstract) J Am Soc Nephrol 4:681, 1993
125. SCHENA FR, MONTENEGRO M, SCIVITTARO V: Meta-analysis of randomized controlled trials in patients with IgA nephropathy (Berger's disease). Nephrol Dial Transplant 5 (Suppl 1):47-52, 1990
126. SOUTHWEST PEDIATRIC NEPHROLOGY STUDY GROUP: Association of IgA nephropathy with steroid-responsive nephrotic syndrome. Am J Kidney Dis 5:157-164, 1985
127. HOGG RJ, SAVINO DA: Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy. Pediatr Nephrol 4:36-38, 1990
128. WOO KT, EDMUNDSON RPS, YAP HK, WU AYT, CHIANG GSC, LEE EJC, PWEE HS, LIM CH: Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 27:56-64, 1987
129. WOO KT, CHIANG GSC, LIM CH: Follow-up renal biopsies in IgA nephritic patients on triple therapy. Clin Nephrol 27:304-305, 1987
130. WALKER RG, YU SH, OWEN JE, KINCAID-SMITH P: The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole, and warfarin: A two year prospective trial. Clin Nephrol 34:103-107, 1990
131. LAI KN, LAI FM, LI PKT, VALLANCE-OWEN J: Cyclosporin treatment of IgA nephropathy: A short-term controlled trial. Brit Med J 295:1165-1168, 1987
132. MIURA M, ENDOH M, NOMOTO Y, SAKAI H: Long-term effect of urokinase therapy in IgA nephropathy. Clin Nephrol 32:209-216, 1989
133. BÉNÉ MC, HURAULT DE LIGNY B, KESSLER M, FOLIGUET B, FAURE GC: Tonsils in IgA nephropathy. Contrib Nephrol 104:153-161, 1993
134. HOLMAN RT, JOHNSON SB, BIBUS D, SPENCER DC, DONADIO JV: Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy. Am J Kidney Dis 23:648-654, 1994
135. ROSTOKER G, PECH M-A, DEL PRATO S, PETIT-PHAR M, BEN MAADI A, DUBERT JM, LANG P, WEIL B, LAGRUE G: Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura. Clin Exp Immunol 75:30-34, 1989
136. ROSTOKER G, DESVAUX-BELGHITI D, PILATTE Y, PETIT-PHAR M, PHILLPON C, DESFORGES L, TERZIDIS H, INTRATOR L, ANDRE C, ADNOT S, BONIN P, BIERLING P, REMY P, LAGRUE G, WEIL B: High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schoenlein purpura. Ann Int Med 120:476-484, 1994
137. REKOLA S, BERGSTRAND L, BUCHT H: Deterioration rate in hypertensive IgA nephropathy: Comparison of a converting enzyme inhibitor and β blocking agents. Nephron 59:57-60, 1991
138. CATTRAN DC, GREENWOOD C, RITCHIE S: Long-term benefit of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254, 1994
139. CAMERON JS: The future of nephrology with special regard to advances in treatment. Kidney Int 42:8203-5214, 1992
140. COUSER WG: Research opportunities and future directions in glomerular disease. Semin Nephrol 13:457-471, 1993
141. BERGER J: Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12:371-372, 1988
142. BACHMAN U, BIAVA C, AMEND W, FEDUSKA N, MELZER J, SALVATIERRA O, VINCENTI F: The clinical course of IgA nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation 42:511-515, 1986
143. WEISS JH, BHATHENA DB, CURTIS JJ, LUCAS BA, LUKE RG: A possible relationship between Henoch-Schoenlein syndrome and IgA nephropathy (Berger's disease): An illustrative case. Nephmn 22: 582-589, 1978
144. SILVA FG, CHANDER P, PIRANI CL, HARDY MA: Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:214-216, 1982
145. ODUM J, PEH CA, CLARKSON AR, BANNISTER KM, SEYMOUR AE, GILLIS D, THOMAS AC, MATHEW TH, WOODROFFE AJ: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309-312, 1994
146. MITSUISHI Y, CECKA JM: Disease effects and association, in Clinical Transplants 1992 edited by TERASAKI PI, CECKA JM, Los Angeles, UCLA Tissue Typing Laboratory, 1993, pp 371-381
147. LIM EC, CHAI D, GJERTSON DW, KOKA P, TERASAXI PI: In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 55:996-999, 1993
148. COSIO FG, FALKENHAIN M, CARLTON S, COSIO MJ: Association of thin glomerular basement membrane nephropathy (TGBM) with other glomerulopathies. (abstract) J Am Soc Nephrol 4:261, 1993